The rapidly declining prevalence of Helicobacter pylori infection and widespread use of
potent anti-secretory drugs means peptic ulcer disease has become substantially less …

Background & Aims Helicobacter pylori infection is increasingly difficult to treat. The purpose
of these consensus statements is to provide a review of the literature and specific, updated …

Important progress has been made in the management of Helicobacter pylori infection and
in this fifth edition of the Maastricht Consensus Report, key aspects related to the clinical role …

Abstract Background Since “Helicobacter pylori (H. pylori) infection” was set as the
indication in the Japanese Society for Helicobacter Research (JSHR) Guidelines 2009 …

Рос журн гастроэнтерол гепатол колопроктол 2018; 28 (3)/Rus J Gastroenterol Hepatol
Coloproctol 2018; 28 (3) путей и вторичным нарушением сократимости; возможно …

Helicobacter pylori Infection is formally recognised as an infectious disease, an entity that is
now included in the International Classification of Diseases 11th Revision. This in principle …

In most regions of the world, antimicrobial resistance has increased to the point where
empirical standard triple therapy for Helicobacter pylori eradication is no longer …

Background The decreasing efficacy of H. pylori eradication treatments over time makes the
search for better regimens and adjuvant medications a priority. Aim To conduct a meta …

Abstract The Japanese Society of Gastroenterology (JSGE) revised the evidence-based
clinical practice guidelines for peptic ulcer disease in 2014 and has created an English …

Background The optimal duration for Helicobacter pylori (H. pylori) eradication therapy is
controversial, with recommendations ranging from 7 to 14 days. Several systematic reviews …